• Privacy policy
  • T&C’s
  • About Us
    • FAQ
    • Meet the Team
  • Contact us
TLE ONLINE SHOP!
  • TLE
  • News
  • Politics
  • Business
  • Sport
  • Opinion
  • Elevenses
  • Entertainment
    • All Entertainment
    • Film
    • Lifestyle
      • Horoscopes
    • Lottery Results
      • Lotto
      • Thunderball
      • Set For Life
      • EuroMillions
  • Food
    • All Food
    • Recipes
  • Property
  • Travel
  • Tech/Auto
No Result
View All Result
The London Economic
SUPPORT THE LONDON ECONOMIC
NEWSLETTER
  • TLE
  • News
  • Politics
  • Business
  • Sport
  • Opinion
  • Elevenses
  • Entertainment
    • All Entertainment
    • Film
    • Lifestyle
      • Horoscopes
    • Lottery Results
      • Lotto
      • Thunderball
      • Set For Life
      • EuroMillions
  • Food
    • All Food
    • Recipes
  • Property
  • Travel
  • Tech/Auto
No Result
View All Result
The London Economic
No Result
View All Result
Home Lifestyle Health

New drug combination could benefit ovarian cancer patients

Researchers said they are “delighted” with the results and are hopeful they will mean a “significant advance” in treatment.

Andra Maciuca by Andra Maciuca
2021-09-19 19:06
in Health, News
Photo: PA

Photo: PA

FacebookTwitterLinkedinEmailWhatsapp

Thousands of women suffering from ovarian cancer could benefit from a drug combination which shrinks tumours in half of patients at an advanced stage. 

VS-6766 and defactinib block signals cancer cells need to grow, and offer a new treatment for a type of ovarian cancer which rarely responds to chemotherapy or hormone therapy, The Guardian has reported.

Researchers said they are “delighted” with the results and are hopeful they will mean a “significant advance” in the treatment of low-grade serous ovarian cancer, which tends to develop at a younger age. 

In trial results involving 24 patients, almost half saw their tumours shrink significantly after the treatment – and 64 per cent of patients with KRAS-driven mutation tumours had the same result. 

Blood test for cancers

In June, it emerged that a simple blood test capable of detecting over 50 types of cancer before any symptoms was being rolled out by NHS England.

The test is said to identify cancers which are difficult to diagnose early, such as oesophageal, ovarian, pancreatic, head and neck and blood cancers.

The test is being piloted by NHS for those over the age of 50, who are at higher risk of cancer.

RelatedPosts

Good Friday agreement: People moved by Liam Neeson’s cameo in final episode of Derry Girls

Anger as Govt brands Disability News Service ‘vexatious’ for trying to acquire info on DWP deaths

BBC says govt took broadcaster to court to block story of MI5 agent using secret status to terrorise girlfriend

Elon Musk says sexual harassment claims should be viewed though ‘political lens’

And scientists say the test has a very low false positive rate.

US Dr Eric Klein, chairman of the Glickman Urological and Kidney Institute in Cleveland and first author on the paper, said: “Finding cancer early, when treatment is more likely to be successful, is one of the most significant opportunities we have to reduce the burden of cancer.

Study results

The test, developed by US-based company Grail, was twice as effective (at 65.6 per cent) finding solid tumours such as oesophageal, liver and pancreatic than it was finding those that have screening options, such as breast, bowel, cervical and prostate cancers.

Lymphoma and myeloma were detected at a rate of 55.1 per cent, and the tissue in which the cancer was located in the body was found in 88.7 per cent of the cases.

Dr Klein said: “We believe that cancers that shed more cfDNA into the bloodstream are detected more easily.

“These cancers are also more likely to be lethal, and prior research shows that this multi-cancer early detection test more strongly detects these cancer types.

“Cancers such as prostate shed less DNA than other tumours, which is why existing screening tests are still important for these cancers.”

The results of the NHS Grail pilot, which is due to start this autumn and will include 140,000 participants, are expected by 2023.

Professor Peter Johnson, national NHS clinical director for cancer, said: “This latest study provides further evidence that blood tests like this could help the NHS meet its ambitious target of finding three-quarters of cancers at an early stage, when they have the highest chance of cure.”

Related: New blood test piloted by NHS can find 50 types of cancer

Tags: cancer

Since you are here

Since you are here, we wanted to ask for your help.

Journalism in Britain is under threat. The government is becoming increasingly authoritarian and our media is run by a handful of billionaires, most of whom reside overseas and all of them have strong political allegiances and financial motivations.

Our mission is to hold the powerful to account. It is vital that free media is allowed to exist to expose hypocrisy, corruption, wrongdoing and abuse of power. But we can't do it without you.

If you can afford to contribute a small donation to the site it will help us to continue our work in the best interests of the public. We only ask you to donate what you can afford, with an option to cancel your subscription at any point.

To donate or subscribe to The London Economic, click here.

The TLE shop is also now open, with all profits going to supporting our work.

The shop can be found here.

You can also SUBSCRIBE TO OUR NEWSLETTER .

Subscribe to our Newsletter

View our  Privacy Policy and Terms & Conditions

Trending on TLE

  • All
  • trending
Abdollah

‘Rescue us’: Afghan teacher begs UK to help him escape Taliban

CHOMSKY: “If Corbyn had been elected, Britain would be pursuing a much more sane course”

What If We Got Rid Of Prisons?

More from TLE

Women want DIY…men demand better sex

Hotel staff brand doting dad a paedo after mistaking daughter for groomed underage girl

No plan in Budget from Chancellor to relieve strain on workers, claims Union

Tory ‘free speech’ law ‘gives free rein to extremists on campus’

Minister claims there are shortages ‘across Europe’. Europeans disagree.

National newspapers gun for “fool of six” Boris following lockdown blunder

Signs of staleness in Donald Trump’s campaign

Need of a Buddy to Move Along –Man and Van Services in London

Theresa May’s ‘breathless wooing’ of Donald Trump a great pity – Bercow

Watch: Greta Thunberg’s stark warning to world leaders ahead of COP26

About Us

TheLondonEconomic.com – Open, accessible and accountable news, sport, culture and lifestyle.

Read more

© 2019 thelondoneconomic.com - TLE, International House, 24 Holborn Viaduct, London EC1A 2BN. All Rights Reserved.




No Result
View All Result
  • Home
  • News
  • Politics
  • Business
  • Sport
  • Entertainment
  • Lifestyle
  • Food
  • Travel
  • More…
    • Elevenses
    • Opinion
    • Property
    • Tech & Auto
  • About Us
    • Meet the Team
    • Privacy policy
  • Contact us

© 2019 thelondoneconomic.com - TLE, International House, 24 Holborn Viaduct, London EC1A 2BN. All Rights Reserved.